AmbryScore
For more information about your patient’s breast or prostate cancer risk, opt into AmbryScore.
AmbryScore is a polygenic risk score (PRS) designed to estimate an individualized risk for certain cancer types using genetic information. The test can be added to select multigene panels and provides a cancer risk assessment based on the combined effects of a number of single nucleotide polymorphisms (SNPs), which have been previously associated with the relevant cancer type.
Why is this important?
Provides additional cancer risk information
Enables healthcare providers to better guide medical management
Contribute to longitudinal data to further the understanding of the clinical impact of a PRS
